drugset / Trial / NCT03528967
Enoxaparin in the Prevention of Placental Insufficiency in Pregnant Women
RandomizedParallel-groupOpen-labelPrevention
Summary
Assessment of the effectiveness of Enoxaparin, at a preventive dose, combined with Aspirin treatment versus Aspirin only treatment in reducing placental insufficiency in pregnant women.
Timeline
- Start
- 2013-10-23
- Primary completion
- 2018-07-31
- Completion
- 2018-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Enoxaparin sodium | Other / unclassified | 40 mg | Subcutaneous |
| Background | Aspirin | Small molecule | 100 mg | Oral |